Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 55 Drugs for Deficiency Anemias.

Slides:



Advertisements
Similar presentations
ANEMIA IN PREGNANCY O+G Update 2014 Hospital Sarikei.
Advertisements

Dr. Soban sadiq. Oral Therapy: Ferrous Sulphate Ferrous Fumarate Ferrous Gluconate Parenteral Therapy: Iron Dextran Iron-sucrose complex Iron sodium.
Drugs used in the treatment of Anemia
Anti-Anemia Agents Broyles Chapter 22 Lehmkuhl, 2009.
Anemia in chronic kidney disease
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 55 Anemia Drugs.
Alterations of Erythrocyte Function
Agents Used to Treat Anemias. Anemia Decreased number of circulating red blood cells Decreased hemoglobin = decreased oxygen capacity Many causes. 22.
HEMATOPOIETIC AND ANTI- ANEMIA AGENTS February 18, 2014 Thomas M. Guenthner, PhD 407D, MSB
MLAB Hematology Keri Brophy-Martinez
ANEMIA DRUGS DSN KEVIN DOBI, MS, APRN Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Chapter 54.
IRON 7 mg/1000 cal in diet; 10% absorbed Heme iron absorbed best, Fe 2+ much better than Fe 3+ –Some foods, drugs enhance and some inhibit absorption of.
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
Iron Metabolism Mike Clark, M.D.. Normal Iron Values Serum iron 52 – 169 micrograms per deciliter Total Iron Binding Capacity 246 – 455 micrograms per.
MEGALOBLASTIC ANEMIAS Nada Mohamed Ahmed, MD, MT (ASCP)i.
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
Megaloblastic anemias MA are a group of disorders characterized by defective nuclear maturation caused impaired DNA synthesis. This is usually due to vitamin.
Antianemics Prof. Hanan Hagar
Anemias. Body Contents of Iron Structure of Hemoglobin.
Clinical aspects of Maternal and Child Nursing NUR 363 Lecture 8.
The blood cells may lack enough hemoglobin, the protein that gives blood its red color. Anemia affects one in 10 teen girls and women. It also develops.
Iron Metabolism HMIM224.
Causes Blood loss – usually from uterus or GI tract Increased demands such as growth and pregnancy Decreased absorption – post gastrectomy, Coeliac disease.
Chapter 22 Agents Used to Treat Anemias. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Anemia.
PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT
Systematic name – N-[4(2-Amino-4-hydroxypteridin-6-ylmethylamino)benzoyl]-L(+)-glutamic acid.
Blood Physiology Professor A.M.A Abdel Gader MD, PhD, FRCP (Lond., Edin), FRSH (London) Professor of Physiology, College of Medicine & The Blood Bank,
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
MLAB Hematology Keri Brophy-Martinez Macrocytic Anemias.
 Stored in the body as ferritin  Deficiency result from negative iron balance due to depletion of stores and/or inadequate intake.  Iron deficiency.
TRACE ELEMENTS IRON. IRON METABOLISM DISTRIBUTION OF IRON IN THE BODY Between 50 to 70 mmol (3 to 4 g) of iron are distributed between body compartments.
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 56 Blood-Forming Drugs.
Hematological System KNH 413. Nutritional Anemias Macrocytic –B12, B9, B1, pyridoxine (B??) Decreased ability to synthesize new cells and DNA Microcytic.
What is Anemia? Anemia is having less than normal number of red blood cells or less hemoglobin than normal in the blood. *Microcytic Anemia: Any abnormal.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Metabolism of iron Alice Skoumalová. Iron in an organism:  total 3-4 g (2,5 g in hemoglobin)  heme, ferritin, transferrin  two oxidation states: Fe.
ANAEMIA IN PREGNANCY AHMED ABDULWAHAB. It is the commonest medical disorder of pregnancy. It is the commonest medical disorder of pregnancy. Physiological.
3:48 PM What are they? Vitamins Nutrition. 3:48 PM Nutrition Vitamins Why are we tired without them?
AGENTS FOR MEGALOBLASTIC ANEMIAS. Megaloblastic anemia is treated with folic acid and vitamin B12. Folate deficiencies usually occur secondary to increased.
AGENTS USED FOR IRON DEFICIENCY
IRON DEFICIENCY ANEMIA/ ANEMIA OF CHRONIC DISEASE
Nada Mohamed Ahmed, MD, MT (ASCP)i. Definition. Physiology of iron. Causes of iron deficiency. At risk group. Stages of IDA (pathophysiology). Symptoms.
Drugs used in Anemia :Lecture outline 1. Definition 2. Types of supplements 3. Clinical pharmacology for each 4. Important indications and adverse effects.
Diagnosis of Megaloblastic Anemia
Objectives : When you complete this section ,you should be able to :
Chapter 22 Agents Used to Treat Anemias. Anemia p526 Decrease in hemoglobin or decrease in RBCs Many causes of anemia – Iron deficiency anemia – Chemotherapy.
Iron Deficiency Anemia Iron Metabolism: Iron Metabolism: IRON INTAKE (Dietary) - “ average ” adult diet = mg Fe/day - absorption = 5-10% (0.5-2 mg/day)
 A 30 year old male presents to you with complaints of easy fatigability, lack of concentration, breathlessness on performing normal daily activities.
Hematologic Problems Klecka, Spring 2016.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Focus on Anemia.
Haematinic Drugs Course: Pharmacology I Course Code: PHR 213 Course Instructor: Md. Samiul Alam Rajib Senior Lecturer Department of Pharmacy BRAC University.
MEGALOBLASTIC ANEMIAS Nada Mohamed Ahmed, MD, MT (ASCP)i.
DRUGS USED TO TREAT Anemias Presented by Dr. Sasan Zaeri ParmD, PhD Fall, 2015.
MLAB Hematology Keri Brophy-Martinez
ROLE OF IRON IN HEALTH AND DISEASE
Iron Metabolism and Anemia
Folic acid deficiency.
MEGALOBLASTIC ANAEMIA
Hematological System KNH 413.
ANEMIA MAGDI AWAD SASI MAGDI AWAD SASI. NORMAL PERIPHERAL SMEAR.
Hematological System KNH 413.
ANAEMIA IN PREGNANCY AHMED ABDULWAHAB.
Clinical pharmacy laboratory/4 th Class Anemias and blood disorders
Drugs Affecting Blood.
Folic acid deficiency.
Metabolism of iron Alice Skoumalová.
IRON IN HEALTH AND DISEASE Enterocyte Gut ABSORPTION OF IRON Fe+++ Ferritin Fe++ Tf-Fe+++ Fe++ Haem Tf.
Presentation transcript:

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 55 Drugs for Deficiency Anemias

2Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Anemias Anemias  Decrease in erythrocytes (RBCs)  Number  Size  Hemoglobin content  Causes  Blood loss  Hemolysis  Bone marrow dysfunction Deficiency of substances essential for RBC formation and maturation Deficiency of substances essential for RBC formation and maturation

3Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Red Blood Cell Development  Development begins in the bone marrow  Matures in the blood  Evolves through four stages  Healthy development requires:  Healthy bone marrow erythropoietin, iron, and other factors to support DNS synthesis

4Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Biochemistry and Physiology of Iron  Metabolic functions  Fate in the body  Uptake and distribution Uptake into mucosal cells in small intestine Uptake into mucosal cells in small intestine Undergoes storage within mucosal cells Undergoes storage within mucosal cells Undergoes binding to transferrin Undergoes binding to transferrin  Utilization and storage Taken up by cells of the bone marrow Taken up by cells of the bone marrow Taken up by the liver and other tissues Taken up by the liver and other tissues Taken up by muscle Taken up by muscle

5Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Iron in the Body  Fate in the body (cont’d)  Recycling: undergoes continuous recycling  Elimination: 1 mg of iron excreted each day  Regulated through control of intestinal absorption

6Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Iron Deficiency  Most common nutritional deficiency and cause of nutrition-related anemia  Causes  Consequences  Diagnosis

7Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Iron  Daily requirements  Determined by rate of erythrocyte production  Increased requirement during pregnancy  Dietary sources  Available in foods of plant and animal origin

8Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Iron Deficiency: Causes, Consequences, and Diagnosis  Results from an imbalance in iron uptake and iron demand  Causes  Pregnancy (blood volume expansion)  Infancy and early childhood  Chronic blood loss  Consequences  Microcytic, hypochromic anemia

9Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Iron Deficiency: Causes, Consequences, and Diagnosis  Diagnosis  Presence of microcytic, hypochromic erythrocytes  Absence of hemosiderin in bone marrow  Other laboratory work RBC count RBC count Reticulocyte count Reticulocyte count Hemoglobin Hemoglobin Hematocrit Hematocrit Serum iron Serum iron Increased serum iron-binding capacity (IBC) Increased serum iron-binding capacity (IBC)

10Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Oral Iron Preparations I: Iron Salts  Ferrous sulfate  Indications—drug of choice  Prophylactic therapy  Adverse effects  GI disturbances  Staining of teeth  Toxicity

11Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Oral Iron Preparations I: Iron Salts  Drug interactions  Antacids  Tetracycline  Ascorbic acid  Other oral iron salts  Ferrous gluconate, ferrous fumarate, and ferrous aspartate  Carbonyl iron

12Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Parenteral Iron Preparations I: Iron Dextran  Iron dextran (INFeD, DexFerrum)  Used for patients who have experienced intolerable or ineffective oral dosing  Adverse effects  Anaphylactic reactions  Hypotension  Persistent pain with IM injection

13Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Parenteral Iron Preparations II: Sodium Ferric Gluconate Complex and Iron Sucrose  Alternatives to iron dextran  Sodium ferric gluconate (SFGC) (Ferrlecit) Low risk of anaphylaxis Low risk of anaphylaxis  Iron sucrose (Venofer) Limited to patients undergoing chronic hemodialysis Limited to patients undergoing chronic hemodialysis All patients must also receive erythropoietin All patients must also receive erythropoietin  Most common side effects  Hypotension  Cramps  Ferumoxytol  Approved in 2009  Iron deficiency anemia, chronic kidney disease (CKD)

14Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Iron Deficiency Treatment Guidelines  Assessment  Routes of administration  Duration of therapy  Therapeutic combinations

15Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Vitamin B 12 (Cobalamin)  Essential for synthesis of DNA  Absorption requires intrinsic factor  Elimination takes place very slowly  Daily requirement  Dietary sources  Limited to microorganisms  Animal products (liver, dairy products)  Fortified foods

16Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Vitamin B 12 (Cobalamin) Fate in the body  Absorption  Distribution and storage  Elimination

17Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Vitamin B 12 Deficiencies: Causes, Consequences, and Diagnosis  Causes  Usually result of impaired absorption  Regional enteritis  Celiac disease  Absence of intrinsic factor

18Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Vitamin B 12 Deficiencies: Causes, Consequences, and Diagnosis  Consequences  Megaloblastic anemia  Neurologic damage Demyelination of neurons Demyelination of neurons  GI disturbances  Diagnosis  Measurement of plasma B 12  Schilling test

19Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Vitamin B 12 Preparations: Cyanocobalamin  Administration Oral, parenteral, intranasal Oral, parenteral, intranasal  Adverse effects Hypokalemia Hypokalemia  Long-term treatment With lack of intrinsic factor, vitamin B 12 therapy lifelong With lack of intrinsic factor, vitamin B 12 therapy lifelong Potential hazards of folic acid Potential hazards of folic acid

20Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Guidelines for Treating Vitamin B 12 Deficiency  Route of B 12 administration  Treatment of moderate B 12 deficiency  Treatment of severe B 12 deficiency  Long-term treatment  Potential hazard of folic acid

21Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Folic Acid Deficiency  Folic acid  Essential factor for DNA synthesis DNA replication DNA replication Cell division cannot proceed Cell division cannot proceed  Absorbed in the early segment of the small intestine  Significant amounts excreted daily  Daily requirements  Dietary sources: all foods

22Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Folic Acid Anemia: Causes and Consequences  Causes  Poor diet (malnutrition and alcoholism)  Malabsorption syndrome (sprue)  Consequences for developing fetus  Neural tube defects (eg, spina bifida, anencephaly)  Adequate intake before conception is critical  The USPSTF now recommends that women of child-bearing age consume 400 to 800 mcg of supplemental folate each day, in addition to the folate they get in food

23Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Folic Acid Anemia: Causes and Consequences  Consequences for anyone  Megaloblastic anemia  Leukopenia, thrombocytopenia, injury to the oral and GI mucosa  May increase risk of colorectal cancer and atherosclerosis

24Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Folic Acid Preparations  Nomenclature  Folic acid (pteroylglutamic acid)

25Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Guidelines for Treating Folic Acid Deficiency  Choice of treatment modality  Route of administration  Prophylactic use of folic acid  Treatment of severe deficiency